Cancer Therapeutics
Acute Leukemia
Leukemia
Hodgkin's Disease
non-Hodgkin's Lymphoma
Multiple Myeloma
Chronic Lymphocytic Leukemia
Chronic Myelogenous Leukemia
Acute myelocytic and myelomonocytic leukemia
Lung Carcinoma
Head and Neck Carcinoma
Endometrial Carcinoma
Ovarian Carcinoma
Cervical Carcinoma
Breast Carcinoma
Choriocarcinoma
Polycythemia Vera
Testicular Carcinoma
Prostatic Carcinoma
Wilms Tumor
Neuroblastoma
Thyroid Carcinoma
Adrenal Carcinoma
Stomach or Pancreatic Carcinoma
Colon Cancer
Carcinoid
Carcinoid II
Insulinoma
Osteogenic Sarcoma
Melanoma
Acute leukemia/lymphoma:
Primary drugs:
Induction:
vincristine plus prednisone
Remission maintenance (combination of drugs below):
mercaptopurine (Purinethol)
methotrexate
cyclophosphamide (Cytoxan)
Other useful drugs/modalities:
asparaginase (El-spar)
daunorubicin (DaunoXome)
carmustine (BNCU,BiCNU)
cytarabine (ARA-C)
allopurinol (Zyloprim, Purinol)-- supportive agent; xanthine oxidase inhibitor (reduces hyperuricemia)
spinal radiotherapy
return to top menu
Hodgkin's Disease: (stages III and IV)
Primary Drugs:
Combination chemotherapy:
vinblastine (Velban)
doxorubicin (Adriamycin)
dacarbazine (DTIC)
bleomycin (Blenoxane)
lomustine (CCNU,CeeNU)
etoposide (VP-16,VePe-sid)
ifofamide (Ifex)
interferon
mechlorethamine (Mustargen)
vincristine (Oncovin)
procarbazine (Matulane)
prednisone (Deltasone)
Non-Hodgkin's lymphoma:
Combination therapy:
Stem cells transplantation
monoclonal antibody treatment (investigational)
Cytokine therapy (interleukin 12) (investigational)
vaccination
mitoxantrone (Novantrone)
Multiple Myeloma:
melphalan (Alkeran)plus prednisone (Deltasone)
Combination therapy
Chronic lymphocytic leukemia
chlorambucil (Leukeran) and prednisone (Deltasone)(if indicated)
fludarabine (Fludara)
Other useful drug/modalities:
chlorambucil (Leukeran) and prednisone (Deltasone)
cladribine (Leustatin)
Chronic myelogenous leukemia
busulfan (Myleran) or interferon
allogenic bone marrow transplantation (certain patients)
hydroxyurea (Hydrea)
melphalan (Alkeran)
Acute myelocytic and myelomonocytic leukemia:
Combination Therapy:cytarabine (ARA-C) and
mitoxantrone (Novantrone) or
daunorubicin (DaunoXome) or
idarubicin (Idamycin)
thioguanine
allopurinol (Zyloprim, Purinol) -- supportive agent; xanthine oxidase inhibitor (reduces hyperuricemia)
asacitidine (investigational)
amsacrine (investigational)
Lung carcinoma:
etoposide (VP-16,VePe-sid) plus cisplatin (Platinol), vinorelbine (Navelbine)
mitomycin (Mutamycin)
Head and Neck carcinoma:
fluorouracil (5-FU) plus cisplatin (Platinol)
vinorelbine (Navelbine)
Salmon, S. E. and Sartorelli, A. C. Cancer Chemotherapy, in Basic and Clinical Pharmacology, (Katzung, B. G., ed) Appleton-Lange, 1998, pp 903-904 (adapted from table 55-7)